{
    "medicine_id": "42619c8ba4f2a137bd783849eecde3d3cfa67552",
    "platform_id": "DB00023",
    "metadata": {
        "name": "Elspar 10000 iU 1 Injection powder lyophilized for solution",
        "composition": "10000 iU 1 Asparaginase Escherichia coli",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated as a component of a multi agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia ALL FDA Label",
            "contraindications": {
                "disease": "No studies assessing the mutagenic or carcinogenic potential of _E coli_ L asparagine have been conducted In the Ames assay no mutagenic effect was demonstrated when tested against Salmonella typhimurium strains FDA Label No studies have been performed on impairment of fertility FDA Label Following a single intravenous injection of 12 500 to 50 000 International Units L asparagine kg in rabbits edema and necrosis of pancreatic islets were observed The clinical relevance of this finding is unclear as it does not indicate pancreatitis FDA Label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In clinical trials of patients with previously untreated standard risk ALL administration of asparaginase resulted in a decrease of plasma asparagine levels from average of 41 \u03bcM to less than 3 \u03bcM FDA Label The native asparaginase in whom plasma enzyme activity before treatment was greater than 0 1 International Units mL FDA Label In this study cerebrospinal fluid asparagine levels in patients treated with asparaginase decreased from 2 8 \u03bcM pretreatment to 1 0 \u03bcM and 0 3 \u03bcM at day 7 and day 28 of induction respectively FDA Label Native E coli asparaginase results in asparagine depletion in 14 to 23 days following administration A31999",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of liver damage can be increased when Asparaginase Escherichia coli is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The therapeutic efficacy of Enzalutamide can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB12425",
                        "description": "The therapeutic efficacy of Liothyronine I 131 can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The therapeutic efficacy of Neocitrullamon can be increased when used in combination with Asparaginase Escherichia coli"
                    },
                    {
                        "drugbank-id": "DB11100",
                        "description": "The therapeutic efficacy of Allantoin can be increased when used in combination with Asparaginase Escherichia coli"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}